Takeda Pharmaceutical Company Limited (TAK) Q4 FY2025 Earnings Call May 13, 2026 6:00 AM EDT
Company Participants
Christopher David O’Reilly – Global Head of Investor Relations & Global Finance
Christophe Weber – President, CEO & Representative Director
Julie Kim – Interim Head of Global Portfolio Division
Milano Furuta – CFO & Director
Andrew Plump – President of Research & Development and Representative Director
Rhonda Pacheco – President of U.S. Business Unit & U.S. Country Head
Conference Call Participants
Shinichiro Muraoka – Morgan Stanley, Research Division
Hidemaru Yamaguchi – Citigroup Inc., Research Division
Michael Nedelcovych – TD Cowen, Research Division
Matsubara – Nomura Securities Co. Ltd., Research Division
Stephen Barker – Jefferies LLC, Research Division
Tony Ren – Macquarie Research
Miki Sogi – Bernstein Institutional Services LLC, Research Division
Presentation
Christopher David O’Reilly
Global Head of Investor Relations & Global Finance
[Audio Gap] [Operator Instructions]
[Interpreted] Before starting, I’d like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. And please also refer to the important notice on Page 2. We may also refer to non-IFRS financial numbers. For the definition and reconciliations, please refer to the appendix in the presentation.
Now, let’s start today’s presentation. President and CEO, Christophe Weber; CEO-Elect, Julie Kim; Chief Financial Officer, Milano Furuta; R&D President, Andy Plump. They will be presenting followed by Q&A session. Let’s start.
Christophe Weber
President, CEO & Representative Director
Thank you, Chris, and good morning, good afternoon and good evening, everyone. Thank you for joining us today for Takeda year-end earnings call. Today will be my last earnings call as President and CEO of Takeda. It has been a real privilege
Read the full article here
